AGNG


Aging Population ETF

Reasons to Consider AGNG

High Growth Potential

AGNG enables investors to access high growth potential through companies at the leading edge of a long-term, structural demographic trend affecting multiple sectors of the global economy.

Unconstrained Approach

AGNG's composition transcends classic sector, industry, and geographic classifications by tracking an emerging theme.

ETF Efficiency

In a single trade, AGNG delivers access to dozens of companies with high exposure to the Longevity theme.

Key Information As of 11/30/21

Inception Date 05/09/16
Total Expense Ratio 0.50%
Net Assets $59.76 million
NAV $27.41
Fact Sheet

ETF Summary

The Global X Aging Population ETF (AGNG) seeks to invest in companies positioned to serve the world’s growing senior population through exposure to health care, pharmaceuticals, senior living facilities and other sectors that contribute to increasing lifespans and extending quality of life in advanced age.

ETF Objective

The Global X Aging Population ETF (AGNG) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Aging Population Thematic Index.

Trading Details As of 11/30/21

Ticker AGNG
Bloomberg Index Ticker ILNGRNT
CUSIP 37954Y772
ISIN US37954Y7720
Primary Exchange Nasdaq
Shares Outstanding 2,180,000
Number of Holdings 100
30-Day Median Bid-Ask Spread 0.26%

Distributions As of 11/30/21

30-Day SEC Yield 0.74%
Distribution Frequency Semi-Annually

ETF Prices As of 11/30/21

NAV $27.41 Daily Change -$0.48 -1.72%
Market Price $27.49 Daily Change -$0.43 -1.53%

Performance History

As of recent
(09/30/21)
As of recent
(09/30/21)
Fund NAV Market Price Index
1 Year 14.19% 13.41% 14.43%
3 Years 10.02% 9.59% 10.23%
5 Years 13.06% 12.84% 13.35%
Since Inception 13.65% 13.94% 13.94%
1 Year 21.06% 21.24% 21.31%
3 Years 15.61% 15.48% 15.86%
5 Years 15.48% 15.46% 15.78%
Since Inception 13.69% 14.14% 13.98%
Year-to-Date 4.36% 3.98% 4.48%
1 Month -5.47% -6.39% -5.48%
3 Months -4.17% -5.01% -4.18%
Since Inception 99.35% 102.09% 102.28%
Year-to-Date 5.69% 6.14% 5.84%
1 Month 1.27% 2.07% 1.31%
3 Months -2.76% -2.98% -2.72%
Since Inception 101.87% 106.27% 104.92%

Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance of the Fund, when observed, is unusual and investors should not expect such performance to be repeated.

Top Holdings As of 11/30/21

Net Assets (%) Ticker Name SEDOL Market Price ($) Shares Held Market Value ($)
4.79 NOVOB DC NOVO NORDISK A/S-B BHC8X90 106.66 26,828 2,861,398.88
4.23 LLY ELI LILLY & CO 2516152 248.04 10,181 2,525,295.24
4.16 REGN REGENERON PHARMACEUTICALS 2730190 636.53 3,903 2,484,376.59
3.96 EW EDWARDS LIFESCIENCES CORP 2567116 107.31 22,063 2,367,580.53
3.68 RO SW ROCHE HOLDING AG-BR 7108918 412.79 5,327 2,198,956.13
3.44 AZN ASTRAZENECA PLC-SPONS ADR 2989044 54.83 37,535 2,058,044.05
3.38 ABBV ABBVIE INC B92SR70 115.28 17,494 2,016,708.32
3.30 DXCM DEXCOM INC B0796X4 562.59 3,506 1,972,440.54
3.05 BSX BOSTON SCIENTIFIC CORP 2113434 38.07 47,923 1,824,428.61
2.97 JNJ JOHNSON & JOHNSON 2475833 155.93 11,384 1,775,107.12
2.94 SYK STRYKER CORP 2853688 236.63 7,430 1,758,160.90
2.74 MDT MEDTRONIC PLC BTN1Y11 106.70 15,364 1,639,338.80
2.69 BMY BRISTOL-MYERS SQUIBB CO 2126335 53.63 29,971 1,607,344.73
2.52 4519 JP CHUGAI PHARMA CO 6196408 32.41 46,480 1,506,419.48
2.51 AMGN AMGEN INC 2023607 198.88 7,532 1,497,964.16
2.39 ALC SW ALCON INC BJT1GR5 78.58 18,143 1,425,717.48
2.17 BIIB BIOGEN INC 2455965 235.74 5,507 1,298,220.18
2.06 STMN SW STRAUMANN HOLDING AG-REG 7156832 2,114.76 582 1,230,791.01
2.02 WELL WELLTOWER INC BYVYHH4 79.62 15,140 1,205,446.80
1.93 BGNE BEIGENE LTD-ADR BYYWPW6 347.53 3,317 1,152,757.01
1.89 4543 JP TERUMO CORP 6885074 40.76 27,645 1,126,787.26
1.77 4503 JP ASTELLAS PHARMA INC 6985383 15.67 67,657 1,060,334.07
1.76 SGEN SEAGEN INC BLPK4D2 160.00 6,585 1,053,600.00
1.53 GMAB DC GENMAB A/S 4595739 384.13 2,386 916,532.54
1.52 ZBH ZIMMER BIOMET HO 2783815 119.60 7,593 908,122.80
1.47 SOON SW SONOVA HOLDING AG-REG 7156036 374.43 2,341 876,546.90
1.46 068270 KS CELLTRION INC B0C5YV1 174.26 5,008 872,679.52
1.28 UCB BB UCB SA 5596991 108.21 7,079 766,051.03
1.16 PODD INSULET CORP B1XGNW4 288.44 2,408 694,563.52
1.06 FME GR FRESENIUS MEDICA 5129074 59.41 10,687 634,902.25
1.06 VTR VENTAS INC 2927925 46.92 13,521 634,405.32
0.91 INCY INCYTE CORP 2471950 67.72 8,027 543,588.44
0.88 EXAS EXACT SCIENCES CORP 2719951 85.37 6,168 526,562.16
0.86 ABMD ABIOMED INC 2003698 314.78 1,641 516,553.98
0.85 SN/ LN SMITH & NEPHEW PLC 0922320 16.11 31,497 507,337.30
0.84 TFX TELEFLEX INC 2881407 297.42 1,692 503,234.64
0.73 3692 HK HANSOH PHARMACEU BJYKB72 2.04 214,000 437,012.00
0.69 DEMANT DC DEMANT A/S BZ01RF1 47.48 8,641 410,264.89
0.66 AMP IM AMPLIFON SPA B14NJ71 48.54 8,153 395,710.77
0.62 DVA DAVITA INC 2898087 94.50 3,948 373,086.00
0.61 COH AU COCHLEAR LTD 6211798 154.43 2,358 364,147.94
0.58 NVCR NOVOCURE LTD BYSS4X4 93.64 3,678 344,407.92
0.52 UTHR UNITED THERAPEUTICS CORP 2430412 189.50 1,633 309,453.50
0.49 GN DC GN STORE NORD A/S 4501093 57.06 5,134 292,942.95
0.47 NBIX NEUROCRINE BIOSC 2623911 83.25 3,385 281,801.25
0.45 853 HK MICROPORT SCIENTIFIC CORP B676TW7 4.18 64,900 271,393.11
0.40 OHI OMEGA HEALTHCARE 2043274 27.94 8,532 238,384.08
0.37 ORP FP ORPEA 7339451 93.87 2,327 218,446.01
0.34 AED BB AEDIFICA B1G5XP1 133.05 1,514 201,430.40
0.34 BPMC BLUEPRINT MEDICINES CORP BWY52P3 96.20 2,089 200,961.80
0.33 1302 HK LIFETECH SCIENTIFIC CORP BV9FKS0 0.54 368,100 199,729.73
0.33 DNLI DENALI THERAPEUTICS INC BD2B4V0 46.26 4,306 199,195.56
0.33 ALEC ALECTOR INC BJ4LDC4 20.65 9,624 198,735.60
0.33 MNKD MANNKIND CORP BF081J4 4.63 42,151 195,159.13
0.32 ANGO ANGIODYNAMICS INC B00CR04 25.75 7,519 193,614.25
0.32 MMSI MERIT MEDICAL SYSTEMS INC 2580555 62.86 3,027 190,277.22
0.31 EXEL EXELIXIS INC 2576941 16.79 11,144 187,107.76
0.31 LIVN LIVANOVA PLC BYMT0J1 80.16 2,304 184,688.64
0.29 1858 HK BEIJING CHUNLI-H BVVPXP6 2.36 73,900 174,041.83
0.29 4547 JP KISSEI PHARM CO 6494061 20.12 8,560 172,187.59
0.28 AMED AMEDISYS INC 2024332 139.65 1,215 169,674.75
0.28 HALO HALOZYME THERAPEUTICS INC 2975098 32.88 5,153 169,430.64
0.28 ACAD ACADIA PHARMACEU 2713317 19.20 8,797 168,902.40
0.27 CSH-U CN CHARTWELL RETIRE B8S8C94 8.60 18,614 160,050.22
0.26 ITGR INTEGER HOLDINGS CORP BD06LM7 79.74 1,976 157,566.24
0.26 EKTAB SS ELEKTA AB-B SHS B0M42T2 11.79 13,287 156,594.12
0.26 NHC NATIONAL HEALTHCARE CORP 2139731 64.49 2,388 154,002.12
0.26 8086 JP NIPRO CORP 6641599 9.47 16,170 153,091.29
0.26 BKD BROOKDALE SR B0PZN33 5.86 26,075 152,799.50
0.25 RDUS RADIUS HEALTH INC BM68KK1 16.46 9,173 150,987.58
0.25 ARNA ARENA PHARMACEUTICALS INC BF3N4P3 54.49 2,754 150,065.46
0.25 ENSG ENSIGN GROUP INC/THE B1YWPP8 76.33 1,953 149,072.49
0.25 RYM NZ RYMAN HEALTHCARE LTD 6161525 8.35 17,776 148,393.73
0.25 SILK SILK ROAD MEDICAL INC BGHVXJ7 40.58 3,653 148,238.74
0.24 2186 HK LUYE PHARMA GROUP LTD BNQ4GF3 0.46 315,347 144,813.24
0.24 KORI FP KORIAN B1HKRM0 29.40 4,777 140,446.23
0.22 LTC LTC PROPERTIES INC 2498788 31.76 4,143 131,581.68
0.22 NUVA NUVASIVE INC B00GJC2 48.06 2,727 131,059.62
0.21 LHCG LHC GROUP INC B06DT50 114.72 1,115 127,912.80
0.21 SBRA SABRA HEALTH CAR B5NLBP6 12.93 9,846 127,308.78
0.21 NHI NATL HEALTH INVESTORS INC 2626125 52.24 2,411 125,950.64
0.21 AGIO AGIOS PHARMACEUTICALS INC BCBVTX1 35.62 3,437 122,425.94
0.20 FGEN FIBROGEN INC BSDRYR8 12.51 9,666 120,921.66
0.20 ATEC ALPHATEC HOLDINGS INC BD60BG7 11.10 10,479 116,316.90
0.19 1789 HK AK MEDICAL HOLDINGS LTD BFD6SZ0 0.86 131,800 113,104.02
0.18 AMRN AMARIN CORP PLC -ADR 2301938 3.60 30,293 109,054.80
0.18 2500 HK VENUS MEDTECH -H BL6V047 4.96 21,400 106,233.44
0.18 INGN INOGEN INC BJSVLL5 30.55 3,461 105,733.55
0.18 DHC DIVERSIFIED HEAL BKRN595 2.79 37,760 105,350.40
0.17 PHM SM PHARMA MAR SA BMW2GT8 64.50 1,548 99,840.62
0.17 HRTX HERON THERAPEUTICS INC BJ0XLZ3 9.45 10,527 99,480.15
0.16 AERI AERIE PHARMACEUTICALS INC BFRTDG1 10.10 9,603 96,990.30
0.15 GKOS GLAUKOS CORP BYMWL19 43.03 2,144 92,256.32
0.14 PNTG PENNANT GROUP INC/THE BKTC976 20.33 4,114 83,637.62
0.14 CASH 1.00 82,779 82,788.23
0.12 OMER OMEROS CORP B4NB858 7.20 10,283 74,037.60
0.12 EPZM EPIZYME INC B9Z1QZ7 3.27 21,616 70,684.32
0.12 TBPH THERAVANCE BIOPHARMA INC BMNDK09 8.40 8,357 70,198.80
0.11 TCMD TACTILE SYSTEMS BZB1XF2 19.50 3,484 67,938.00
0.11 BLUE BLUEBIRD BIO INC BBFL7S1 10.11 6,275 63,440.25
0.09 TSVT 2SEVENTY BIO INC BMTXV88 26.34 2,093 55,129.62
Holdings are subject to change.

Sector Breakdown As of 10/31/21

Sector Weight (%)
Health Care 94.1
Real Estate 4.8
Information Technology 0.5
Industrials 0.3
Communication Services 0.3

Source: AltaVista Research, LLC

Country Breakdown As of 10/31/21

Country Weight (%)
United States 56.9
Switzerland 9.3
Denmark 7.4
Japan 6.9
Britain 5.3
China 4.2
Ireland 3.1
Belgium 1.6
South Korea 1.3
Germany 1.1
Italy 0.6
Other/Cash 2.3

Source: AltaVista Research, LLC

ETF Characteristics As of 11/30/21

Return on Equity 15.40%
Weighted Avg. Market Cap 88,553 M
2020 2021
Price-to-earnings 30.44 25.07
Price-to-book value 4.07 3.69

Source: AltaVista Research, LLC

ETF Risk Stats As of 11/30/21

Versus Beta
S&P 500 0.77
MSCI EAFE 0.78
MSCI Emg. Mkts 0.63
Standard Deviation 17.70%

Source: AltaVista Research, LLC

ETF Research

Investing involves risk, including the possible loss of principal. The investable universe of companies in which AGNG may invest may be limited. The Fund invests in securities of companies engaged in Healthcare, Pharmaceutical, Biotechnology and Medical Device sectors. These sectors can be affected by government regulations, expiring patents, rapid product obsolescence, and intense industry competition. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. AGNG is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Indxx, nor does Indxx make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Indxx.

AGNG traded under the ticker LNGR from inception until April 1, 2021.